XenoPort, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1999-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://xenoport.com
An Extension Study to Evaluate the Efficacy and Safety of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS
- First Posted Date
- 2015-12-17
- Last Posted Date
- 2021-06-09
- Lead Sponsor
- XenoPort, Inc.
- Target Recruit Count
- 144
- Registration Number
- NCT02633683
- Locations
- 🇺🇸
Dent Neurologic Institute, Amherst, New York, United States
🇺🇸Stanford Sleep Medicine Center, Redwood City, California, United States
🇺🇸Pacific Research Network, San Diego, California, United States
A PK and Safety Evaluation of HORIZANT (Gabapentin Enacarbil) in Adolescents With Moderate-to-Severe Primary RLS
- First Posted Date
- 2015-12-17
- Last Posted Date
- 2021-04-12
- Lead Sponsor
- XenoPort, Inc.
- Registration Number
- NCT02633657
- Locations
- 🇺🇸
Stanford Sleep Medicine Center, Redwood City, California, United States
🇺🇸Vanderbilt University School of Medicine, Nashville, Tennessee, United States
🇺🇸SleepMed of South Carolina; SleepMed, Inc., Columbia, South Carolina, United States
An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS
- First Posted Date
- 2015-09-25
- Last Posted Date
- 2021-06-09
- Lead Sponsor
- XenoPort, Inc.
- Target Recruit Count
- 132
- Registration Number
- NCT02560766
- Locations
- 🇺🇸
NW FL Clinical Research Group, Gulf Breeze, Florida, United States
🇺🇸Stanford Sleep Medicine Center, Redwood City, California, United States
🇺🇸Orlando Pediatric Pulmonary and Sleep, Winter Park, Florida, United States
Gabapentin Enacarbil (GSK1838262) Adult Restless Leg Syndrome (RLS) Post Marketing Commitment Study
- Conditions
- Interventions
- First Posted Date
- 2012-08-20
- Last Posted Date
- 2021-05-24
- Lead Sponsor
- XenoPort, Inc.
- Target Recruit Count
- 501
- Registration Number
- NCT01668667
- Locations
- 🇺🇸
GSK Investigational Site, Charlottesville, Virginia, United States
A Study to Evaluate the Effect of Gabapentin on Cardiac Repolarization in Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2012-01-24
- Last Posted Date
- 2021-04-12
- Lead Sponsor
- XenoPort, Inc.
- Target Recruit Count
- 52
- Registration Number
- NCT01516372
- Locations
- 🇺🇸
GSK Investigational Site, Austin, Texas, United States
Drug Drug Interaction Study With Gabapentin Enacarbil and Morphine
- Conditions
- Interventions
- First Posted Date
- 2011-11-22
- Last Posted Date
- 2013-07-16
- Lead Sponsor
- XenoPort, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT01476124
- Locations
- 🇺🇸
GSK Investigational Site, Austin, Texas, United States
Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2011-08-08
- Last Posted Date
- 2013-07-16
- Lead Sponsor
- XenoPort, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT01411124
- Locations
- 🇺🇸
GSK Investigational Site, Austin, Texas, United States
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
- Conditions
- Interventions
- First Posted Date
- 2011-05-24
- Last Posted Date
- 2021-02-21
- Lead Sponsor
- XenoPort, Inc.
- Target Recruit Count
- 228
- Registration Number
- NCT01359566
- Locations
- 🇺🇸
XenoPort Clinical Site, Tacoma, Washington, United States
Simulated Driving Study in Restless Legs Syndrome
- Conditions
- Interventions
- First Posted Date
- 2011-04-11
- Last Posted Date
- 2013-07-26
- Lead Sponsor
- XenoPort, Inc.
- Target Recruit Count
- 130
- Registration Number
- NCT01332318
- Locations
- 🇺🇸
GSK Investigational Site, Albuquerque, New Mexico, United States
Dose-Response and Pharmacokinetics of Gabapentin Enacarbil (GEn [XP13512 / GSK1838262]) in Restless Legs Syndrome
- Conditions
- Interventions
- First Posted Date
- 2011-04-11
- Last Posted Date
- 2013-07-22
- Lead Sponsor
- XenoPort, Inc.
- Target Recruit Count
- 217
- Registration Number
- NCT01332305
- Locations
- 🇺🇸
GSK Investigational Site, Dallas, Texas, United States